Study #2016-0714
Human Papillomavirus Antibody Response after GARDASIL 9 Vaccination in Patients after Allogeneic Stem Cell Transplantation
MD Anderson Study Status
Not Accepting
Treatment Agent
Recombinant Human Papillomavirus Nonavalent Vaccine
Description
This phase IV trial studies how well Gardasil 9 vaccine works in preventing human papillomavirus (HPV) infection in patients with hematologic malignancies who are undergoing donor stem cell transplant. Vaccines, such as Gardasil 9, may help the body build an effective immune response to kill cancer cells.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Neoplasm
Study phase:
Phase IV
Physician name:
Jessica Hwang
Department:
General Internal Medicine
For general questions about clinical trials:
1-844-513-2253
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.